{"id":"W4235888460","doi":"10.1016/j.jval.2017.08.1392","title":"Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Chile","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Sacubitril; Valsartan; Sacubitril, Valsartan; Enalapril; Medicine; Heart failure; Ejection fraction; Internal medicine; Cardiology; Population; Blood pressure; Angiotensin-converting enzyme","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005654376,0.0001422094,0.0002409163,0.0003034709,0.0001922838,0.0005319374,0.0003270971,0.0002099423,0.002349461],"category_scores_gemma":[0.001009692,0.00006396514,0.0003312512,0.0002918132,0.0002497618,0.0001944424,0.0003830496,0.0006581061,0.0001331732],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001475426,"about_ca_system_score_gemma":0.003014081,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01633158,"about_ca_topic_score_gemma":0.02372251,"domain_scores_codex":[0.999765,0.0001180994,0.00002111533,0.00001654339,0.00002296483,0.00005624229],"domain_scores_gemma":[0.9996395,0.00006786978,0.00008717412,0.0000174941,0.00007013755,0.0001176493],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02387376,0.006374664,0.3699531,0.004449422,0.001199119,0.00368428,0.001276631,0.002607657,0.02101734,0.01097141,0.01936618,0.5352265],"study_design_scores_gemma":[0.004768967,0.004983806,0.9210459,0.001143967,0.00135709,0.001401578,0.002977545,0.003096468,0.005054959,0.003680733,0.05039222,0.00009672666],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9587764,0.01822097,0.0006989905,0.01340685,0.0001722645,0.00007502204,0.0009299201,0.00004540433,0.007674102],"genre_scores_gemma":[0.9909729,0.005573682,0.0008274192,0.0007109763,0.0001344202,0.00004706763,0.0003521065,0.000008190867,0.00137317],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01633158,"threshold_uncertainty_score":0.03247303,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05498248345565799,"score_gpt":0.3490184198887912,"score_spread":0.2940359364331332,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}